Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11927544 | 0.94 | CYP3A4 (0.46) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL5354836 | 0.87 | CYP3A4 (0.52) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL28186037 | 0.83 | CYP3A4 (0.38) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL19822055 | 0.83 | CYP3A4 (0.48) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL29460338 | 0.83 | CYP3A4 (0.48) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL24627648 | 0.83 | LMNA (0.46) | CYP3A4L3MBTL1TSHRCA2MAPK1 | |
| SCHEMBL24627500 | 0.83 | LMNA (0.46) | CYP3A4L3MBTL1TSHRCA2MAPK1 | |
| SCHEMBL24627677 | 0.83 | LMNA (0.46) | CYP3A4L3MBTL1TSHRCA2MAPK1 | |
| SCHEMBL13492153 | 0.82 | CYP3A4 (0.46) | CYP3A4L3MBTL1TSHRTDP1ATM | |
| SCHEMBL30940561 | 0.82 | CYP3A4 (0.47) | CYP3A4L3MBTL1TSHRTDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180066105-A1 | RESIN MODIFIER AND RESIN COMPOSITION USING SAME | ADEKA CORPORATION (JP) | 2018-03-08 | — | — | US | disclosed |
| US-20160274273-A1 | RETARDATION-INCREASING AGENT, CELLULOSE-BASED RESIN COMPOSITION USING SAME, AND FILM | ADEKA CORPORATION (JP) | 2016-09-22 | — | — | US | disclosed |
| US-7993613-B2 | aldoxime extractants with optional ketoxime extractants; branched chain ether equilibrium modifiers; 2-hydroxy-5-heptylbenzaldoxime; tert-butyl octyl ether; copper sulfate | COGNIS IP MANAGEMENT GMBH (DE) | 2011-08-09 | — | — | US | disclosed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | disclosed |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | disclosed |
| EP-2104542-A2 | MORE EFFICIENT ETHER MODIFIERS FOR COPPER EXTRACTANT FORMULATIONS | Cognis IP Management GmbH (DE) | 2009-09-30 | — | — | EP | disclosed |
| EP-1673166-A4 | ZIEGLER-NATTA CATALYST FOR POLYOLEFINS | FINA TECHNOLOGY (US) | 2009-06-17 | — | — | EP | disclosed |
| US-20080193398-A1 | Derivatives of Heptaazaphenalene, Methods for Obtaining Them, and Their Use as Protecting Agents Against Uv Radiation | ISDIN, S.A. (ES) | 2008-08-14 | — | — | US | disclosed |
| US-20080193398-A1 | Derivatives of Heptaazaphenalene, Methods for Obtaining Them, and Their Use as Protecting Agents Against Uv Radiation | ISDIN, S.A. (ES) | 2008-08-14 | — | — | US | disclosed |
| US-20080175772-A1 | MORE EFFICIENT ETHER MODIFIERS FOR COPPER EXTRACTANT FORMULATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-07-24 | — | — | US | disclosed |
| WO-2008088473-A2 | MORE EFFICIENT ETHER MODIFIERS FOR COPPER EXTRACTANT FORMULATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-07-24 | — | — | WO | disclosed |
| EP-1673166-A1 | ZIEGLER-NATTA CATALYST FOR POLYOLEFINS | FINA TECHNOLOGY, INC. (US) | 2006-06-28 | — | — | EP | disclosed |
| US-20050085601-A1 | Process for forming Ziegler-Natta catalyst for use in polyolefin production | FINA TECHNOLOGY, INC. | 2005-04-21 | — | — | US | disclosed |
| WO-2005032714-A1 | ZIEGLER-NATTA CATALYST FOR POLYOLEFINS | FINA TECHNOLOGY, INC. (US) | 2005-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193398-A1 | Derivatives of Heptaazaphenalene, Methods for Obtaining Them, and Their Use as Protecting Agents Against Uv Radiation | ERCC4, XPA, CYP51A1 | CYP3A4 107/4885L3MBTL1 4826/4885TSHR 4144/4885 |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | CYP3A4 202/4885L3MBTL1 4788/4885TSHR 2328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.